Article Detail - JE Part B
Self-Administered Drug Exclusion List (A53032) - R37 - Effective July 1, 2024
Date Posted: July 18, 2024
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: July 1, 2024
Summary of Changes:
The article has been updated due to a clerical error in the previous revision. The article has been updated to add a new code (Q5137) for Ustekinumab-auub (Wezlana) effective for dates of service on or after 7/1/2024.
Visit the Self-Administered Drugs (SADs) webpage to view the Self-Administered Drug Exclusion List.
To view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.